Impax Asset Management Group plc Has $125.84 Million Stake in Itron, Inc. $ITRI

Key Points

• Impax Asset Management cut its stake in Itron by 14.7% in Q4 to 1,355,148 shares (2.96%) valued at $125.84 million, and institutional/hedge funds now own about 96.19% of the company.
• Itron beat Q4 estimates with EPS of $2.46 (vs. $2.19 expected) and revenue of $571.7M (vs. $561.3M), though revenue was down 6.7% year‑over‑year; management set Q1 FY2026 EPS guidance of 1.20–1.30 and FY2026 EPS guidance of 5.75–6.25.
• Analyst sentiment is mixed: the consensus is a "Moderate Buy" with a $133.10 average target, while firms range from JPMorgan cutting its target to $113 to Oppenheimer raising theirs to $135 and Raymond James initiating coverage with an "underperform" rating.

Impax Asset Management Group plc decreased its holdings in Itron, Inc. (NASDAQ:ITRI - Free Report) by 14.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,355,148 shares of the scientific and technical instruments company's stock after selling 233,802 shares during the quarter. Impax Asset Management Group plc owned 2.96% of Itron worth $125,839,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its position in Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company's stock worth $53,000 after purchasing an additional 81 shares in the last quarter. Amalgamated Bank increased its position in Itron by 0.7% during the 3rd quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company's stock worth $1,627,000 after purchasing an additional 86 shares in the last quarter. PFG Investments LLC increased its position in Itron by 4.8% during the 3rd quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company's stock worth $256,000 after purchasing an additional 94 shares in the last quarter. Xponance Inc. increased its position in Itron by 3.2% during the 3rd quarter. Xponance Inc. now owns 3,757 shares of the scientific and technical instruments company's stock worth $468,000 after purchasing an additional 115 shares in the last quarter. Finally, Oliver Luxxe Assets LLC increased its position in Itron by 0.5% during the 4th quarter. Oliver Luxxe Assets LLC now owns 24,960 shares of the scientific and technical instruments company's stock worth $2,318,000 after purchasing an additional 127 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Stock Down 0.0%

Itron stock opened at $88.55 on Friday. Itron, Inc. has a 1-year low of $83.51 and a 1-year high of $142.00. The firm has a market capitalization of $3.92 billion, a price-to-earnings ratio of 13.60, a price-to-earnings-growth ratio of 0.78 and a beta of 1.50. The firm's fifty day moving average price is $93.00 and its two-hundred day moving average price is $100.57. The company has a current ratio of 1.80, a quick ratio of 1.56 and a debt-to-equity ratio of 0.45.

Itron (NASDAQ:ITRI - Get Free Report) last announced its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.19 by $0.27. The company had revenue of $571.66 million during the quarter, compared to the consensus estimate of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The firm's revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, equities research analysts predict that Itron, Inc. will post 5.99 earnings per share for the current fiscal year.

Insider Buying and Selling at Itron

In other news, SVP Laurie Ann Pulatie-Hahn sold 729 shares of Itron stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $73,023.93. Following the completion of the transaction, the senior vice president owned 32,950 shares in the company, valued at $3,300,601.50. This trade represents a 2.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Joan S. Hooper sold 3,533 shares of Itron stock in a transaction dated Thursday, February 26th. The stock was sold at an average price of $95.92, for a total transaction of $338,885.36. Following the completion of the transaction, the chief financial officer owned 118,275 shares of the company's stock, valued at $11,344,938. The trade was a 2.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 51,180 shares of company stock valued at $5,085,475 in the last three months. 1.77% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have weighed in on ITRI. JPMorgan Chase & Co. reduced their target price on shares of Itron from $133.00 to $113.00 and set an "overweight" rating on the stock in a report on Thursday, April 16th. Oppenheimer boosted their target price on shares of Itron from $133.00 to $135.00 and gave the stock an "outperform" rating in a report on Thursday, April 16th. Raymond James Financial assumed coverage on shares of Itron in a report on Tuesday. They set an "underperform" rating on the stock. Wall Street Zen lowered shares of Itron from a "buy" rating to a "hold" rating in a research note on Wednesday, January 14th. Finally, Guggenheim set a $155.00 price objective on shares of Itron in a research note on Friday, February 13th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $133.10.

Itron Company Profile

Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.